Detalles de la búsqueda
1.
Efficacy and Safety of Adding Lurasidone to Ongoing Therapy With Lithium or Valproate for the Treatment of an Acute Bipolar Depressive Episode: A Post Hoc Analysis of 2 Placebo-Controlled Trials.
J Clin Psychopharmacol
; 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38639433
2.
Lurasidone and risk of metabolic syndrome: results from short and long-term studies in patients with bipolar depression.
CNS Spectr
; 28(6): 680-687, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36961124
3.
Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study.
CNS Spectr
; 27(1): 118-128, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33077012
4.
Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data.
Curr Ther Res Clin Exp
; 94: 100629, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34306269
5.
C-reactive protein and response to lurasidone treatment in children and adolescents with bipolar I depression: Results from a placebo-controlled trial.
Brain Behav Immun
; 84: 269-274, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31857217
6.
Lurasidone and risk for metabolic syndrome: results from short- and long-term clinical studies in patients with schizophrenia.
CNS Spectr
; : 1-11, 2020 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32921337
7.
Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study.
BMC Psychiatry
; 20(1): 199, 2020 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32370778
8.
Association of C-reactive protein and metabolic risk with cognitive effects of lurasidone in patients with schizophrenia.
Compr Psychiatry
; 102: 152195, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32896775
9.
Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study -- CORRIGENDUM.
CNS Spectr
; 27(1): 129, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33998439
10.
Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression.
Curr Neuropharmacol
; 21(6): 1393-1404, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36173066
11.
The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression: A Post Hoc Analysis.
J Clin Psychiatry
; 84(4)2023 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37339360
12.
The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.
Alzheimers Dement
; 8(3): 237-42, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22546356
13.
Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis.
Schizophr Res
; 240: 205-213, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032906
14.
Impact of lurasidone on health-related quality of life in adults with bipolar depression: a post-hoc analysis.
Curr Med Res Opin
; 38(9): 1613-1619, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35699377
15.
The impact of lurasidone on functioning and indirect costs in adults with bipolar depression: a post-hoc analysis.
J Med Econ
; 25(1): 152-159, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35037813
16.
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies.
Int Clin Psychopharmacol
; 37(5): 215-222, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35276716
17.
Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression.
J Child Adolesc Psychopharmacol
; 31(7): 494-503, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34324397
18.
Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies.
Eur Psychiatry
; 64(1): e35, 2021 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33966678
19.
Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies.
Int J Chron Obstruct Pulmon Dis
; 16: 865-875, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33833507
20.
Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial.
J Child Adolesc Psychopharmacol
; 30(10): 590-598, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32392455